BIOTEK INSTRUMENTS acquired by AGILENT TECHNOLOGIES
Context
Agilent has finalized the acquisition of BioTek Instruments in an all-cash transaction, a maneuver designed to fundamentally expand its capabilities in the critical cell analysis technology sector. The strategic rationale for this transaction centers on a "workflow-simplification" play, merging the target's industry-leading expertise in microplate detection and imaging with the group’s established presence in live-cell, real-time analysis. This structural alignment provides the organization with the scientific talent and technological hardware required to address the increasing complexity of immunotherapy and biologics research. This operation allows the group to execute a definitive structural expansion of its biopharma and academic service offerings.
BIOTEK INSTRUMENTS, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Industry & Manufacturing sector (11.7x).
-> Deep-dive in Industry & Manufacturing market trends
Target
BioTek Instruments is a USA company specialized in Life Science Instrumentation. They are recognized as a leader in the design and manufacture of innovative microplate instrumentation and software that allow scientists to visualize and quantify cellular interactions. Instead of offering generic lab tools, they thrive on a philosophy of technical precision, providing high-performance imaging and multi-mode detection systems that are critical for drug discovery and immunotherapy research. What makes them a go-to partner is their knack for integrating complex imaging software with automated hardware, helping academic and biopharma researchers obtain deep insights into complex cellular environments.
Ent. Value
$1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Industrial Equipment
Similar deals in Industrial Equipment
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2019 | VOITH GROUP | BTG | SWITZERLAND | Instrumentation & Measurement |
| 09/2019 | CAPITAL EXPORT | REPACK-S | FRANCE | Valves, Pumps & Taps |
| 08/2019 | TELEDYNE TECHNOLOGIES INCORPORATED | 3M GAS AND FLAME DETECTION | FRANCE | Instrumentation & Measurement |
| 02/2019 | DANAHER | GE LIFE SCIENCES | UNITED STATES | Lab & Scientific Equipment |
| 01/2019 | ARDIAN | CELLI GROUP | ITALY | Food & Beverage Lines |
| 12/2018 | HITACHI | ABB Power Grids | SWITZERLAND | Electrical Equipment |
| 09/2018 | GROUPE ATLANTIC | ACV | BELGIUM | Boilers & Thermal Solutions |
| 07/2018 | TSINGHUA UNIGROUP | LINXENS | FRANCE | Safety & Security |
| 07/2018 | MAREL | MAJA | GERMANY | Food & Beverage Lines |
| 07/2018 | ARDIAN | COROB | ITALY | Special Machinery |
Other operations with AGILENT TECHNOLOGIES
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2024 | AGILENT TECHNOLOGIES | BIOVECTRA | CANADA | CDMO |
REFERENCES
Valuation range: EV $1–10bn
EBITDA range: $50–100M
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of BIOTEK INSTRUMENTS by AGILENT TECHNOLOGIES are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: agilent technologies